amiodarone has been researched along with Pregnancy in 95 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone, a benzofuranic derivative, iodine-rich drug, has been used in pregnancy for either maternal or fetal tachyarrhythmias." | 8.81 | Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. ( Bartalena, L; Bogazzi, F; Braverman, LE; Martino, E, 2001) |
| "A case of the use of amiodarone in pregnancy is reported and the literature on this subject reviewed." | 8.77 | Amiodarone in pregnancy. Case report and review of the literature. ( Foster, CJ; Love, HG, 1988) |
| "Amiodarone, a broad-spectrum antiarrhythmic drug, is widely used for the clinical treatment of tachyarrhythmias because of its safety and efficacy." | 7.91 | Aggravation of atrial arrhythmia by amiodarone during the perinatal period: A case report. ( Chen, H; Jiang, W; Lin, W; Pan, B; Wang, Y; Ye, F, 2019) |
| "We report a case of nonimmune hydrops fetalis caused by atrial flutter, which was successfully treated by intraperitoneal and intra-amniotic injections of amiodarone." | 7.83 | Successful treatment of atrial flutter by repeated intraperitoneal and intra-amniotic injections of amiodarone in a fetus with hydrops. ( Hsieh, CT; Lin, PH; Tsai, HD; Wu, HH, 2016) |
| "Fetuses with incessant tachycardia and either hydrops fetalis (n=24) or ventricular dysfunction (n=2) for whom digoxin monotherapy and secondary antiarrhythmic agents (n=13) were not effective were treated transplacentally with a loading dose of oral amiodarone for 2 to 7 days, followed by daily maintenance therapy for <1 to 15 weeks." | 7.72 | Amiodarone therapy for drug-refractory fetal tachycardia. ( Cuneo, BF; Deal, BJ; Feinkind, L; Gotteiner, NL; Hussey, M; McGregor, SN; Meijboom, EJ; Michon, MM; Oudijk, MA; Parilla, BV; Strasburger, JF, 2004) |
| "We present a case of persistent fetal supraventricular tachycardia where transplacental and direct fetal treatment with amiodarone caused an iatrogenic hypothyroidism." | 7.69 | Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia. ( Bougatef, A; De Catte, L; De Schepper, J; De Wolf, D; Foulon, W; Smitz, J, 1994) |
| "Gestational exposure to amiodarone may be complicated by perinatal hypothyroidism or hyperthyroidism and possibly neurologic abnormalities, intrauterine growth retardation or fetal bradycardia." | 7.69 | Pregnancy outcome after gestational exposure to amiodarone in Canada. ( Allen, LC; Boulton, BC; Downar, E; Koren, G; Magee, LA; Sermer, M, 1995) |
| "Five cases are studied in which amiodarone (AM) was given during pregnancy, in two of them also during the breast feeding period, to estimate the risks for adverse effects." | 7.68 | Use of amiodarone during pregnancy. ( de Vijlder, JJ; Plomp, TA; Vulsma, T, 1992) |
| "Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 7.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
| "A case study is presented in which amiodarone (A) was given during the whole of pregnancy and during the breast feeding period." | 7.67 | Amiodarone during pregnancy. ( Andreasen, F; Frandsen, J; Strunge, P, 1988) |
| "The role that the new antiarrhythmic agents, such as verapamil and amiodarone, might play in the therapeutic strategy of tachycardia-induced fetal heart failure remains to be determined." | 7.67 | Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone: a case report. ( Duperron, L; Gauthier, R; Grignon, A; LeLorier, J; Lemay, M; Rey, E, 1985) |
| "Two cases are reported in which amiodarone was administered during pregnancy for longer periods than has been reported previously." | 7.67 | Use of amiodarone during pregnancy. ( Holt, DW; Jeeva Raj, MV; Robson, DJ; Storey, GC, 1985) |
| "Amiodarone (AMD) is an antiarrhythmic agent which contains 37% of iodine." | 6.44 | [Transient neonatal hypothyroidism due to amiodarone administration during pregnancy--two cases report and review of literature]. ( Boguszewski, MC; Lacerda Filho, Ld; Nesi-França, S; Pavan-Senn, CC; Pelaez, J; Pereira, RM; Sandrini Neto, R, 2008) |
| "Amiodarone is an iodine-rich drug used to treat cardiac dysrhythmias." | 6.42 | Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism. ( Backeljauw, PF; Jackson, WA; Lomenick, JP, 2004) |
| "Iodine is an essential element for thyroid hormone synthesis." | 6.41 | Iodine-Induced hypothyroidism. ( Georgopoulos, N; Kyriazopoulou, V; Markou, K; Vagenakis, AG, 2001) |
| "Amiodarone (AMD) is an antiarrhythmic drug which contains 37% of iodine." | 5.30 | Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases. ( Berardi, R; Cioni, M; Grosso, S; Morgese, G, 1998) |
| "Amiodarone is a class III anti-arrhythmic compound that is iodinated, cationic and amphiphilic in nature." | 5.28 | Effects of amiodarone administration during pregnancy in Fischer 344 rats. ( Hill, DA; Reasor, MJ, 1991) |
| "Amiodarone is an anti-arrhythmic drug with a content of 39% Iodine." | 5.27 | Congenital hypothyroid goiter and amiodarone. ( De Schepper, J; De Wolf, D; Deneyer, M; Sacre-Smits, L; Smitz, J; Verhaaren, H, 1988) |
| "The off-label use of OCAs was reviewed for the management of neonatal and adult Graves' disease, subacute thyroiditis, amiodarone-induced thyroiditis (AIT), exogenous hyperthyroidism, toxic multinodular goiter (TMNG), thyrotropinoma, thyrotoxicosis during pregnancy, rapid pre-operative control of hyperthyroidism, and thyroid storm." | 4.90 | Review of oral cholecystographic agents for the management of hyperthyroidism. ( Kim, TY; Martinez, DS; Tyer, NM, 2014) |
| "To summarize the mechanisms of iodine-induced hypothyroidism and hyperthyroidism, identify the risk factors for thyroid dysfunction following an iodine load, and summarize the major sources of excess iodine exposure." | 4.88 | Iodine-induced thyroid dysfunction. ( Braverman, LE; Leung, AM, 2012) |
| "Amiodarone, a benzofuranic derivative, iodine-rich drug, has been used in pregnancy for either maternal or fetal tachyarrhythmias." | 4.81 | Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. ( Bartalena, L; Bogazzi, F; Braverman, LE; Martino, E, 2001) |
| "A case of the use of amiodarone in pregnancy is reported and the literature on this subject reviewed." | 4.77 | Amiodarone in pregnancy. Case report and review of the literature. ( Foster, CJ; Love, HG, 1988) |
| "Amiodarone, a broad-spectrum antiarrhythmic drug, is widely used for the clinical treatment of tachyarrhythmias because of its safety and efficacy." | 3.91 | Aggravation of atrial arrhythmia by amiodarone during the perinatal period: A case report. ( Chen, H; Jiang, W; Lin, W; Pan, B; Wang, Y; Ye, F, 2019) |
| "We report a case of nonimmune hydrops fetalis caused by atrial flutter, which was successfully treated by intraperitoneal and intra-amniotic injections of amiodarone." | 3.83 | Successful treatment of atrial flutter by repeated intraperitoneal and intra-amniotic injections of amiodarone in a fetus with hydrops. ( Hsieh, CT; Lin, PH; Tsai, HD; Wu, HH, 2016) |
| "Fetuses with incessant tachycardia and either hydrops fetalis (n=24) or ventricular dysfunction (n=2) for whom digoxin monotherapy and secondary antiarrhythmic agents (n=13) were not effective were treated transplacentally with a loading dose of oral amiodarone for 2 to 7 days, followed by daily maintenance therapy for <1 to 15 weeks." | 3.72 | Amiodarone therapy for drug-refractory fetal tachycardia. ( Cuneo, BF; Deal, BJ; Feinkind, L; Gotteiner, NL; Hussey, M; McGregor, SN; Meijboom, EJ; Michon, MM; Oudijk, MA; Parilla, BV; Strasburger, JF, 2004) |
| " We evaluated the clinical performance of nine FT4 assays in five centres, using a panel of 310 sera: 156 from euthyroid controls; 27 from hyperthyroid patients; 34 from untreated hypothyroidism; 22 from patients with renal failure; 30 from women in the last trimester of pregnancy; 23 from patients on thyroid substitutive therapy; and 18 from patients treated with amiodarone." | 3.72 | Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations. ( Beaudonnet, A; d'Herbomez, M; Forzy, G; Gasser, F; Massart, C; Sapin, R, 2003) |
| " After failure of initial transplacental treatment, the injection of amiodarone into the umbilical vein combined with evacuation of ascites achieved conversion to sinus rhythm and restored cardiac function thus allowing pregnancy to go to term." | 3.70 | Successful treatment of refractory supraventricular tachycardia by repeat intravascular injection of amiodarone in a fetus with hydrops. ( Guyon, F; Horovitz, J; Jimenez, M; Mangione, R; Saura, R; Vergnaud, A, 1999) |
| " Compared to age-matched controls, FT3 decreased in pregnancy, NTlm, NTlc, and amiodarone groups." | 3.70 | Evaluation of Elecsys free triiodothyronine assay: relevance of age-related reference ranges. ( Gasser, F; Goichot, B; Grucker, D; Sapin, R; Schlienger, JL, 1998) |
| "Gestational exposure to amiodarone may be complicated by perinatal hypothyroidism or hyperthyroidism and possibly neurologic abnormalities, intrauterine growth retardation or fetal bradycardia." | 3.69 | Pregnancy outcome after gestational exposure to amiodarone in Canada. ( Allen, LC; Boulton, BC; Downar, E; Koren, G; Magee, LA; Sermer, M, 1995) |
| "We present a case of persistent fetal supraventricular tachycardia where transplacental and direct fetal treatment with amiodarone caused an iatrogenic hypothyroidism." | 3.69 | Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia. ( Bougatef, A; De Catte, L; De Schepper, J; De Wolf, D; Foulon, W; Smitz, J, 1994) |
| "Five cases are studied in which amiodarone (AM) was given during pregnancy, in two of them also during the breast feeding period, to estimate the risks for adverse effects." | 3.68 | Use of amiodarone during pregnancy. ( de Vijlder, JJ; Plomp, TA; Vulsma, T, 1992) |
| "Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 3.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
| "A case study is presented in which amiodarone (A) was given during the whole of pregnancy and during the breast feeding period." | 3.67 | Amiodarone during pregnancy. ( Andreasen, F; Frandsen, J; Strunge, P, 1988) |
| " Euthyroid hyperthyroxinemia may occur: as a response to abnormal plasma binding (thyroxine binding globulin, albumin, prealbumin, or autoantibodies), because of hormone resistance, after exposure to drugs such as amiodarone, cholecystographic contrast agents, or propranolol, during acute psychiatric illness or stress, and in hyperemesis gravidarum." | 3.67 | The diagnostic challenge of euthyroid hyperthyroxinemia. ( Barlow, JW; Stockigt, JR, 1985) |
| "Two cases are reported in which amiodarone was administered during pregnancy for longer periods than has been reported previously." | 3.67 | Use of amiodarone during pregnancy. ( Holt, DW; Jeeva Raj, MV; Robson, DJ; Storey, GC, 1985) |
| "The role that the new antiarrhythmic agents, such as verapamil and amiodarone, might play in the therapeutic strategy of tachycardia-induced fetal heart failure remains to be determined." | 3.67 | Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone: a case report. ( Duperron, L; Gauthier, R; Grignon, A; LeLorier, J; Lemay, M; Rey, E, 1985) |
| "Treatment options for Graves' disease include antithyroid drugs, radioactive iodine therapy, and surgery, whereas antithyroid drugs are not generally used long term in toxic nodular goitre, because of the high relapse rate of thyrotoxicosis after discontinuation." | 2.53 | Hyperthyroidism. ( Braverman, LE; De Leo, S; Lee, SY, 2016) |
| "The most frequent cause is Graves' disease (autoimmune hyperthyroidism)." | 2.48 | Thyrotoxicosis. ( Boelaert, K; Franklyn, JA, 2012) |
| "Amiodarone (AMD) is an antiarrhythmic agent which contains 37% of iodine." | 2.44 | [Transient neonatal hypothyroidism due to amiodarone administration during pregnancy--two cases report and review of literature]. ( Boguszewski, MC; Lacerda Filho, Ld; Nesi-França, S; Pavan-Senn, CC; Pelaez, J; Pereira, RM; Sandrini Neto, R, 2008) |
| "Emergencies include arrhythmias, acute coronary syndrome, peripartum cardiomyopathy and hypertensive disorders." | 2.44 | [Arrhythmias during pregnancy]. ( Trappe, HJ, 2008) |
| "We report a case of nonimmune hydrops fetalis detected at 32 weeks of gestation." | 2.43 | Amiodarone in treatment of fetal supraventricular tachycardia. A case report and review of literature. ( Kapoor, A; Manisha, M; Pradhan, M; Singh, R, 2006) |
| "Amiodarone is an iodine-rich drug used to treat cardiac dysrhythmias." | 2.42 | Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism. ( Backeljauw, PF; Jackson, WA; Lomenick, JP, 2004) |
| " Its chronic administration may lead to disturbances in thyroid hormone metabolism and/or overt gland dysfunction." | 2.42 | [Amiodarone and the thyroid gland]. ( Bednarek-Tupikowska, G; Bugajski, J; Filus, A; Kuliczkowska, J, 2004) |
| "Amiodarone is a benzofuranic-derivative iodine-rich drug widely used for the treatment of tachyarrhythmias and, to a lesser extent, of ischemic heart disease." | 2.41 | The effects of amiodarone on the thyroid. ( Bartalena, L; Bogazzi, F; Braverman, LE; Martino, E, 2001) |
| "Iodine is an essential element for thyroid hormone synthesis." | 2.41 | Iodine-Induced hypothyroidism. ( Georgopoulos, N; Kyriazopoulou, V; Markou, K; Vagenakis, AG, 2001) |
| "Thyrotoxicosis is a well defined clinical entity, determined by an increase of plasma levels of thyroid hormones (T3 and T4)." | 2.41 | [The management of thyrotoxicosis: a schematic approach]. ( Carapezzi, C; Corsello, SM; Papi, G, 2002) |
| " Investigators have hoped that these drugs would be as effective as sotalol and amiodarone but have fewer adverse effects." | 2.40 | The side effect profile of class III antiarrhythmic drugs: focus on d,l-sotalol. ( MacNeil, DJ, 1997) |
| "Amiodarone was injected slowly into foetal peritoneal cavity under ultrasound guidance." | 1.42 | Foetal supraventricular tachycardia with hydrops fetalis: a role for direct intraperitoneal amiodarone. ( Coleman, M; Gnanapragasam, J; Howe, D; Kang, SL; Roman, K, 2015) |
| "The amiodarone was stopped 3 weeks later as she was pregnant." | 1.38 | Oral amiodarone provoking inferior ST elevation and unmasking Brugada-like electrocardiogram feature. ( Braganza, D; Jassam, Y; Lee, CW; Virdee, M, 2012) |
| "Amiodarone is the treatment of choice for direct foetal therapy for SVT, and can be administered safely via the umbilical vein." | 1.35 | [Treatment of foetal supraventricular tachycardia with antiarrhythmic medication administered through the umbilical vein]. ( Blom, NA; Klumper, FJ; Oepkes, D; Rijlaarsdam, ME; Roest, AA; Vandenbussche, FP, 2008) |
| "Ventricular tachycardia is rare and poorly understood in the neonate." | 1.30 | [Neonatal ventricular tachycardia]. ( Acar, P; Aggoun, Y; Bonnet, D; Butera, G; Kachaner, J; Villain, E, 1998) |
| "Most arrhythmias associated with fetal hydrops can be controlled with transplacental treatment, but the mortality in this group is 27%." | 1.30 | Fetal tachycardias: management and outcome of 127 consecutive cases. ( Sharland, GK; Simpson, JM, 1998) |
| "Amiodarone therapy was continued with the addition of propanolol." | 1.30 | Prenatal diagnosis of a familial form of junctional ectopic tachycardia. ( Azancot, A; Denjoy, I; Lupoglazoff, JM; Luton, D; Magnier, S, 1999) |
| "Amiodarone (AMD) is an antiarrhythmic drug which contains 37% of iodine." | 1.30 | Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases. ( Berardi, R; Cioni, M; Grosso, S; Morgese, G, 1998) |
| "The supraventricular tachycardia is a life threatening state in the intrauterine life." | 1.29 | [Successful treatment of fetal supraventricular tachycardia with a combination of digoxin and amiodarone]. ( Hajdú, J; Német, J; Szabó, I, 1996) |
| "Amiodarone is a class III anti-arrhythmic compound that is iodinated, cationic and amphiphilic in nature." | 1.28 | Effects of amiodarone administration during pregnancy in Fischer 344 rats. ( Hill, DA; Reasor, MJ, 1991) |
| "Fetal cardiac arrhythmias are usually first suspected on the basis of auscultatory findings during routine examination in pregnancy." | 1.27 | Treatment of fetal cardiac arrhythmias. ( Stewart, PA; Wladimiroff, JW, 1985) |
| "Amiodarone is an anti-arrhythmic drug with a content of 39% Iodine." | 1.27 | Congenital hypothyroid goiter and amiodarone. ( De Schepper, J; De Wolf, D; Deneyer, M; Sacre-Smits, L; Smitz, J; Verhaaren, H, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (26.32) | 18.7374 |
| 1990's | 24 (25.26) | 18.2507 |
| 2000's | 28 (29.47) | 29.6817 |
| 2010's | 16 (16.84) | 24.3611 |
| 2020's | 2 (2.11) | 2.80 |
| Authors | Studies |
|---|---|
| Ouarda, F | 1 |
| Drissa, M | 1 |
| Hakim, K | 1 |
| Msaad, H | 1 |
| Bjeloševič, M | 1 |
| Illíková, V | 1 |
| Tomko, J | 1 |
| Olejník, P | 1 |
| Chalupka, M | 1 |
| Hatala, R | 1 |
| Környei, L | 1 |
| Szabó, A | 1 |
| Róth, G | 1 |
| Ferenci, T | 1 |
| Kardos, A | 1 |
| Ye, F | 1 |
| Jiang, W | 1 |
| Wang, Y | 1 |
| Lin, W | 1 |
| Chen, H | 1 |
| Pan, B | 1 |
| Lakatos, P | 1 |
| Kang, SL | 1 |
| Howe, D | 1 |
| Coleman, M | 1 |
| Roman, K | 1 |
| Gnanapragasam, J | 1 |
| Tyer, NM | 1 |
| Kim, TY | 1 |
| Martinez, DS | 1 |
| Capone, CA | 1 |
| Gebb, J | 1 |
| Dar, P | 1 |
| Shenoy, RU | 1 |
| Pieper, PG | 1 |
| De Leo, S | 1 |
| Lee, SY | 1 |
| Braverman, LE | 6 |
| Lin, PH | 1 |
| Wu, HH | 1 |
| Tsai, HD | 1 |
| Hsieh, CT | 1 |
| Koukkou, EG | 1 |
| Roupas, ND | 1 |
| Markou, KB | 1 |
| Cuneo, BF | 2 |
| Trappe, HJ | 1 |
| Pézard, PG | 1 |
| Boussion, F | 1 |
| Sentilhes, L | 1 |
| Lépinard, C | 1 |
| Couvreur, MH | 1 |
| Victor, J | 1 |
| Geslin, P | 1 |
| Descamps, P | 1 |
| Cornette, J | 1 |
| ten Harkel, AD | 1 |
| Steegers, EA | 1 |
| Eskes, SA | 1 |
| Wiersinga, WM | 1 |
| Mikovic, Z | 1 |
| Karadzov, N | 1 |
| Jovanovic, I | 1 |
| Milic, V | 1 |
| Tomovic, B | 1 |
| Egic, A | 1 |
| Dragovic Lukic, G | 1 |
| Burrows, K | 1 |
| Fox, J | 1 |
| Biblo, LA | 1 |
| Roth, JA | 1 |
| Lee, CW | 1 |
| Jassam, Y | 1 |
| Braganza, D | 1 |
| Virdee, M | 1 |
| Franklyn, JA | 1 |
| Boelaert, K | 1 |
| Leung, AM | 1 |
| Takitoh, T | 1 |
| Kumamoto, K | 1 |
| Wang, CC | 1 |
| Sato, M | 1 |
| Toba, S | 1 |
| Wynshaw-Boris, A | 1 |
| Hirotsune, S | 1 |
| Aurengo, A | 1 |
| Leenhardt, L | 1 |
| Aurengo, H | 1 |
| Tomek, V | 1 |
| Marek, J | 1 |
| Spálová, I | 1 |
| Vlk, R | 1 |
| Janousek, J | 1 |
| Bresták, M | 1 |
| Kulovaný, E | 1 |
| Skovránek, J | 1 |
| Doherty, G | 1 |
| Bali, S | 1 |
| Casey, F | 1 |
| Jouannic, JM | 1 |
| Delahaye, S | 1 |
| Le Bidois, J | 1 |
| Fermont, L | 1 |
| Villain, E | 2 |
| Dommergues, M | 1 |
| Dumez, Y | 1 |
| d'Herbomez, M | 1 |
| Forzy, G | 1 |
| Gasser, F | 2 |
| Massart, C | 1 |
| Beaudonnet, A | 1 |
| Sapin, R | 2 |
| Strasburger, JF | 1 |
| Michon, MM | 1 |
| Gotteiner, NL | 1 |
| Deal, BJ | 1 |
| McGregor, SN | 1 |
| Oudijk, MA | 1 |
| Meijboom, EJ | 1 |
| Feinkind, L | 1 |
| Hussey, M | 1 |
| Parilla, BV | 1 |
| Bednarek-Tupikowska, G | 1 |
| Filus, A | 1 |
| Kuliczkowska, J | 1 |
| Bugajski, J | 1 |
| Lomenick, JP | 1 |
| Jackson, WA | 1 |
| Backeljauw, PF | 1 |
| Malvino, E | 1 |
| Bruno, MC | 1 |
| Gallo, JP | 1 |
| Medrano, JC | 1 |
| Ferrante, D | 1 |
| Pradhan, M | 1 |
| Manisha, M | 1 |
| Singh, R | 1 |
| Kapoor, A | 1 |
| Korecki, J | 1 |
| Kamiński, KA | 1 |
| Lisowska, A | 1 |
| Musiał, WJ | 1 |
| Pavan-Senn, CC | 1 |
| Nesi-França, S | 1 |
| Pelaez, J | 1 |
| Pereira, RM | 1 |
| Boguszewski, MC | 1 |
| Sandrini Neto, R | 1 |
| Lacerda Filho, Ld | 1 |
| Roest, AA | 1 |
| Vandenbussche, FP | 1 |
| Klumper, FJ | 1 |
| Oepkes, D | 1 |
| Rijlaarsdam, ME | 1 |
| Blom, NA | 1 |
| Pitcher, D | 1 |
| Leather, HM | 1 |
| Storey, GC | 2 |
| Holt, DW | 2 |
| McKenna, WJ | 2 |
| Rowland, E | 2 |
| Krikler, DM | 1 |
| Harris, L | 1 |
| Whitelaw, A | 1 |
| Storey, G | 1 |
| Holt, D | 1 |
| Candelpergher, G | 1 |
| Buchberger, R | 1 |
| Suzzi, G | 1 |
| Padrini, R | 1 |
| Magee, LA | 1 |
| Downar, E | 1 |
| Sermer, M | 1 |
| Boulton, BC | 1 |
| Allen, LC | 1 |
| Koren, G | 1 |
| Moro Serrano, C | 1 |
| Hernández Madrid, A | 1 |
| Lage Silveira, J | 1 |
| Vivas Alvarez, E | 1 |
| Kanjhi, M | 1 |
| De Catte, L | 2 |
| De Wolf, D | 2 |
| Smitz, J | 4 |
| Bougatef, A | 2 |
| De Schepper, J | 3 |
| Foulon, W | 2 |
| Foster, CJ | 2 |
| Ovadia, M | 1 |
| Brito, M | 1 |
| Hoyer, GL | 1 |
| Marcus, FI | 1 |
| Amiel, C | 1 |
| Chau, C | 1 |
| Millet, V | 1 |
| Agher, JP | 1 |
| Gamerre, M | 1 |
| Fulgencio, JP | 1 |
| Hamza, J | 1 |
| Hajdú, J | 1 |
| Szabó, I | 1 |
| Német, J | 1 |
| MacNeil, DJ | 1 |
| Schlienger, JL | 1 |
| Goichot, B | 1 |
| Grucker, D | 1 |
| Butera, G | 1 |
| Bonnet, D | 1 |
| Acar, P | 1 |
| Aggoun, Y | 1 |
| Kachaner, J | 1 |
| Grosso, S | 1 |
| Berardi, R | 1 |
| Cioni, M | 1 |
| Morgese, G | 1 |
| Simpson, JM | 1 |
| Sharland, GK | 1 |
| Lupoglazoff, JM | 1 |
| Denjoy, I | 1 |
| Luton, D | 1 |
| Magnier, S | 1 |
| Azancot, A | 1 |
| Mangione, R | 1 |
| Guyon, F | 1 |
| Vergnaud, A | 1 |
| Jimenez, M | 1 |
| Saura, R | 1 |
| Horovitz, J | 1 |
| Schleich, JM | 1 |
| Bernard Du Haut Cilly, F | 1 |
| Laurent, MC | 1 |
| Almange, C | 2 |
| Schmolling, J | 1 |
| Renke, K | 1 |
| Richter, O | 1 |
| Pfeiffer, K | 1 |
| Schlebusch, H | 2 |
| Höller, T | 1 |
| Joglar, JA | 1 |
| Page, RL | 1 |
| Bartalena, L | 3 |
| Bogazzi, F | 3 |
| Martino, E | 3 |
| Vanbesien, J | 1 |
| Casteels, A | 1 |
| De Bock, S | 1 |
| Markou, K | 1 |
| Georgopoulos, N | 1 |
| Kyriazopoulou, V | 1 |
| Vagenakis, AG | 1 |
| Gasperi, M | 1 |
| Dereure, O | 1 |
| Papi, G | 1 |
| Carapezzi, C | 1 |
| Corsello, SM | 1 |
| Bennett, DH | 1 |
| Gribbin, B | 1 |
| Birkhead, JS | 1 |
| Valensise, H | 1 |
| Civitella, C | 1 |
| Garzetti, GG | 1 |
| Romanini, C | 1 |
| Darwiche, A | 1 |
| Vanlieferinghen, P | 1 |
| Lemery, D | 1 |
| Paire, M | 1 |
| Lusson, JR | 1 |
| Matsumura, LK | 1 |
| Born, D | 1 |
| Kunii, IS | 1 |
| Franco, DB | 1 |
| Maciel, RM | 1 |
| Hijazi, ZM | 1 |
| Rosenfeld, LE | 1 |
| Copel, JA | 1 |
| Kleinman, CS | 1 |
| Plomp, TA | 1 |
| Vulsma, T | 1 |
| de Vijlder, JJ | 1 |
| Aguilar Diosdado, M | 1 |
| Jáen Amate, F | 1 |
| Gavilán Villarejo, I | 1 |
| Merino López, FJ | 1 |
| Widerhorn, J | 1 |
| Bhandari, AK | 1 |
| Bughi, S | 1 |
| Rahimtoola, SH | 1 |
| Elkayam, U | 1 |
| Hill, DA | 1 |
| Reasor, MJ | 1 |
| Suárez Ortega, S | 1 |
| Franco Cebrián, J | 1 |
| Medina Fernández-Aceytuno, A | 1 |
| Armas Portela, M | 1 |
| Méndez Mora, D | 1 |
| Estévez Zarazaga, A | 1 |
| Tubman, R | 1 |
| Jenkins, J | 1 |
| Lim, J | 1 |
| Gembruch, U | 1 |
| Manz, M | 1 |
| Bald, R | 1 |
| Rüddel, H | 1 |
| Redel, DA | 1 |
| Nitsch, J | 1 |
| Hansmann, M | 1 |
| Hotton, JM | 1 |
| Marchand, X | 1 |
| Baron, B | 1 |
| Zannier, D | 1 |
| Pathe, M | 1 |
| Boulet, E | 1 |
| Rocha, P | 1 |
| Kahn, JC | 1 |
| Love, HG | 1 |
| Vanderborght, J | 1 |
| Van Steirteghem, AC | 1 |
| Strunge, P | 1 |
| Frandsen, J | 1 |
| Andreasen, F | 1 |
| Verhaaren, H | 1 |
| Deneyer, M | 1 |
| Sacre-Smits, L | 1 |
| Bretremieux, P | 1 |
| Laurent, M | 2 |
| Lefrançois, C | 1 |
| Belhassen, A | 1 |
| Vaksmann, G | 1 |
| Francart, C | 1 |
| Vinatier, D | 1 |
| Patey, P | 1 |
| Monnier, JC | 1 |
| Koblin, DD | 1 |
| Romanoff, ME | 1 |
| Martin, DE | 1 |
| Hensley, FA | 1 |
| Larach, DR | 1 |
| Stauffer, RA | 1 |
| Luck, JC | 1 |
| Rey, E | 2 |
| Bachrach, LK | 1 |
| Burrow, GN | 1 |
| Vlahot, N | 1 |
| Morvan, J | 1 |
| Bernard, AM | 1 |
| Cleophax, JP | 1 |
| Firmin, J | 1 |
| Betremieux, P | 1 |
| Biron, Y | 1 |
| LeHelloco, A | 1 |
| Arnoux, P | 1 |
| Seyral, P | 1 |
| Llurens, M | 1 |
| Djiane, P | 1 |
| Potier, A | 1 |
| Unal, D | 1 |
| Cano, JP | 1 |
| Serradimigni, A | 1 |
| Rouault, F | 1 |
| Wladimiroff, JW | 1 |
| Stewart, PA | 1 |
| Stockigt, JR | 1 |
| Barlow, JW | 1 |
| Robson, DJ | 1 |
| Jeeva Raj, MV | 1 |
| Penn, IM | 1 |
| Barrett, PA | 1 |
| Pannikote, V | 1 |
| Barnaby, PF | 1 |
| Campbell, JB | 1 |
| Lyons, NR | 1 |
| Duperron, L | 1 |
| Gauthier, R | 1 |
| Lemay, M | 1 |
| Grignon, A | 1 |
| LeLorier, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Local Betamethasone Versus Triamcinolone Injection in Management of Thyroid-Related Upper Lid Retraction With and Without Proptosis[NCT04976816] | Phase 2/Phase 3 | 92 participants (Actual) | Interventional | 2021-12-01 | Completed | ||
| A Randomized, Open-label, Parallel-group Study to Explore the Efficacy of High-intensity Focused Ultrasound (HIFU) Versus Fixed-dose Radioiodine-131 in the Treatment of Relapsed Graves' Disease[NCT03013257] | 240 participants (Actual) | Interventional | 2017-04-25 | Completed | |||
| Hypothyroidism After the TAVI Procedure in Elderly Patients[NCT04831957] | 20 participants (Anticipated) | Interventional | 2021-07-26 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
24 reviews available for amiodarone and Pregnancy
| Article | Year |
|---|---|
Review of oral cholecystographic agents for the management of hyperthyroidism.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Goiter, Nodular; Humans; Hyperthyroidism; Neoplas | 2014 |
Use of medication for cardiovascular disease during pregnancy.
Topics: Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascul | 2015 |
Hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Amiodarone; Antithyroid Agents; Diagnosis, Differential; Drug Administr | 2016 |
Effect of excess iodine intake on thyroid on human health.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hyperthyroidism; Hypothyroidi | 2017 |
[Arrhythmias during pregnancy].
Topics: Adenosine; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Impla | 2008 |
Amiodarone and thyroid.
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Female; Humans; Hypothyroidism; Male; Pregnancy; Pr | 2009 |
Thyrotoxicosis.
Topics: Agranulocytosis; Amiodarone; Antithyroid Agents; Atrial Fibrillation; Autoimmune Diseases; Child; Ex | 2012 |
Iodine-induced thyroid dysfunction.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Dietary Supplements; | 2012 |
[Amiodarone and the thyroid gland].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Glucocorticoids; Humans; Hy | 2004 |
Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism.
Topics: Amiodarone; Anti-Arrhythmia Agents; Congenital Hypothyroidism; Female; Fetal Diseases; Humans; Hypot | 2004 |
Amiodarone in treatment of fetal supraventricular tachycardia. A case report and review of literature.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Echocardiography, Dop | 2006 |
[Transient neonatal hypothyroidism due to amiodarone administration during pregnancy--two cases report and review of literature].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cognition Disorders; Congenital Hypothyroidism; Female; Humans; | 2008 |
Amiodarone: the experience of the past decade.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Drug Interactions; | 1983 |
[Amiodarone in the nineties: to whom and what dosage?].
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Clinical Trials | 1995 |
The side effect profile of class III antiarrhythmic drugs: focus on d,l-sotalol.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Conduction System; Heart Failur | 1997 |
Antiarrhythmic drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Heart | 2001 |
Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment.
Topics: Amiodarone; Female; Humans; Hypothyroidism; Infant, Newborn; Lactation; Maternal-Fetal Exchange; Ner | 2001 |
The effects of amiodarone on the thyroid.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Hormone Replacement Therapy; Humans; | 2001 |
Iodine-Induced hypothyroidism.
Topics: Amiodarone; Drug Synergism; Female; Goiter; Humans; Hypothyroidism; Infant, Newborn; Iodides; Iodine | 2001 |
The various effects of amiodarone on thyroid function.
Topics: Amiodarone; Female; Humans; Hypothyroidism; Male; Pregnancy; Thyroid Diseases; Thyroid Gland; Thyrot | 2001 |
Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimalari | 2001 |
[The management of thyrotoxicosis: a schematic approach].
Topics: Adenoma; Adrenal Cortex Hormones; Adult; Aged; Amiodarone; Antithyroid Agents; Cardiovascular Diseas | 2002 |
Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy.
Topics: Adult; Amiodarone; Female; Fetal Diseases; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infan | 1991 |
Amiodarone in pregnancy. Case report and review of the literature.
Topics: Adult; Amiodarone; Electrocardiography; Female; Fetal Heart; Humans; Pregnancy; Pregnancy Complicati | 1988 |
71 other studies available for amiodarone and Pregnancy
| Article | Year |
|---|---|
Fetal Persistent junctional reciprocating tachycardia : a diagnostic and a therapeutic challenge.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Echocardiography; Ele | 2019 |
Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10-year population-based study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Pregna | 2020 |
Supraventricular tachycardias in neonates and infants: factors associated with fatal or near-fatal outcome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Female; Humans; Infant; Infant, Newborn; Pregnancy; Retro | 2021 |
Aggravation of atrial arrhythmia by amiodarone during the perinatal period: A case report.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Heart Failure; Humans; Pre- | 2019 |
[Editor's commentary. Advances in endocrinology].
Topics: Amiodarone; Anti-Arrhythmia Agents; Diabetic Neuropathies; Endocrine System Diseases; Female; Humans | 2013 |
Foetal supraventricular tachycardia with hydrops fetalis: a role for direct intraperitoneal amiodarone.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetus; Gestational Age; Heart Rate, Fetal; Humans | 2015 |
Favorable neurodevelopmental outcome in a hypothyroid neonate following intracordal amiodarone for cardioversion of refractory supraventricular tachycardia in a fetus.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Hydrops Fetalis; Hypothyr | 2014 |
Successful treatment of atrial flutter by repeated intraperitoneal and intra-amniotic injections of amiodarone in a fetus with hydrops.
Topics: Adult; Amiodarone; Amnion; Anti-Arrhythmia Agents; Atrial Flutter; Female; Humans; Hydrops Fetalis; | 2016 |
Treatment of fetal tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Electrophysiology; Digoxin; Female; Fetal Diseases; Huma | 2008 |
Fetal tachycardia: a role for amiodarone as first- or second-line therapy?
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Maternal-F | 2008 |
Fetal dilated cardiomyopathy caused by persistent junctional reciprocating tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Blood Flow Velocity; Cardiomyopathy, Dilated; Digoxin; Dr | 2009 |
Developmental delay associated with normal thyroidal function and long-term amiodarone therapy during fetal and neonatal life.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child Development; Child, Preschool; Female; Fetal Diseases; Hum | 2010 |
Pregnancy and short-coupled torsades de pointes.
Topics: Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Defibrillators, Implantable; Female; | 2013 |
Oral amiodarone provoking inferior ST elevation and unmasking Brugada-like electrocardiogram feature.
Topics: Administration, Oral; Adult; Amiodarone; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiograp | 2012 |
Activation of Aurora-A is essential for neuronal migration via modulation of microtubule organization.
Topics: Amiodarone; Analysis of Variance; Animals; Animals, Newborn; Aurora Kinase A; Aurora Kinases; Bromod | 2012 |
[Adaptation of thyroid function to excess iodine].
Topics: Adaptation, Physiological; Adult; Air Pollutants, Radioactive; Amiodarone; Child; Female; Humans; Hy | 2002 |
[Intraumbilical therapy of fetal supraventricular tachycardia].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Infusions, Intravenous; P | 2002 |
Fetal hydrops due to supraventricular tachycardia--successful outcome in a difficult case.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Hydrops Fetalis; Pre | 2003 |
[Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Clinical Protocols; Digoxin; Echocardiography; F | 2003 |
Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations.
Topics: Amiodarone; Anti-Arrhythmia Agents; Blood Chemical Analysis; Female; Humans; Hyperthyroidism; Kidney | 2003 |
Amiodarone therapy for drug-refractory fetal tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Electrocardiography; Female; Fetal Dise | 2004 |
[Fetal supraventricular tachyarrhythmias refractory to initial therapy].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Female; Fetal Diseases; Flecainide; Humans; Male | 2005 |
Supraventricular tachycardia and pulmonary hypertension at the presentation of Hodgkin's disease.
Topics: Adult; Amiodarone; Cesarean Section; Diagnosis, Differential; Echocardiography, Doppler; Electrocard | 2005 |
[Treatment of foetal supraventricular tachycardia with antiarrhythmic medication administered through the umbilical vein].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Hydrops Fetalis; Pregnanc | 2008 |
Amiodarone in pregnancy.
Topics: Adult; Amiodarone; Benzofurans; Female; Fetus; Heart Atria; Humans; Infant, Newborn; Pregnancy; Preg | 1983 |
Amiodarone therapy during pregnancy.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Infant, Newborn; Maternal-Feta | 1983 |
[Trans-placental passage of amiodarone: electrocardiographic evidence and pharmacological findings in a newborn infant].
Topics: Adult; Amiodarone; Benzofurans; Female; Fetus; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pre | 1982 |
Pregnancy outcome after gestational exposure to amiodarone in Canada.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Arrhythmias, Cardiac; Bradycardia; Canada; Cohort St | 1995 |
Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia.
Topics: Adult; Amiodarone; Digoxin; Female; Fetal Diseases; Humans; Hypothyroidism; Infant, Newborn; Male; P | 1994 |
Amiodarone in pregnancy.
Topics: Abnormalities, Drug-Induced; Amiodarone; Female; Heart Defects, Congenital; Humans; Infant, Newborn; | 1994 |
Human experience with amiodarone in the embryonic period.
Topics: Abnormalities, Drug-Induced; Adult; Amiodarone; Female; Humans; Pregnancy; Pregnancy Complications, | 1994 |
[Fetal supraventricular tachycardia. Management].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Digoxin; Drug Therapy, Combination; Female; Fetal Di | 1993 |
Anaesthesia for caesarean section in a patient receiving high dose amiodarone for fetal supraventricular tachycardia.
Topics: Adult; Amiodarone; Anesthesia, Epidural; Anesthesia, Obstetrical; Cesarean Section; Drug Interaction | 1994 |
[Successful treatment of fetal supraventricular tachycardia with a combination of digoxin and amiodarone].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Female; Fetal Death; | 1996 |
Evaluation of Elecsys free triiodothyronine assay: relevance of age-related reference ranges.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amiodarone; Child; Child, Preschool; Female | 1998 |
[Neonatal ventricular tachycardia].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Fetal | 1998 |
Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases.
Topics: Adult; Amiodarone; Female; Fetal Diseases; Humans; Hypothyroidism; Infant, Newborn; Maternal-Fetal E | 1998 |
Fetal tachycardias: management and outcome of 127 consecutive cases.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Chi-Square Distribution; Digoxin; Female; Fetal Distr | 1998 |
Prenatal diagnosis of a familial form of junctional ectopic tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Fetal Diseases; Humans; Infa | 1999 |
Successful treatment of refractory supraventricular tachycardia by repeat intravascular injection of amiodarone in a fetus with hydrops.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Female; Fetal Diseases; Heart Rate, Fetal; Human | 1999 |
Early prenatal management of a fetal ventricular tachycardia treated in utero by amiodarone with long term follow-up.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Gestational Age; Heart Rate, Feta | 2000 |
Digoxin, flecainide, and amiodarone transfer across the placenta and the effects of an elevated umbilical venous pressure on the transfer rate.
Topics: Amiodarone; Anti-Arrhythmia Agents; Area Under Curve; Digoxin; Female; Fetal Diseases; Flecainide; H | 2000 |
Transient fetal hypothyroidism due to direct fetal administration of amiodarone for drug resistant fetal tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Hypothyroidism; Infant, N | 2001 |
Identical twins with differing forms of ventricular pre-excitation.
Topics: Amiodarone; Child; Diseases in Twins; Electrocardiography; Female; Heart; Heart Conduction System; H | 1978 |
Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; Echo | 1992 |
[Amiodarone and fetal supraventricular tachycardia. Apropos of a case with neonatal hypothyroidism].
Topics: Amiodarone; Female; Heart Rate, Fetal; Humans; Hypothyroidism; Infant, Newborn; Maternal-Fetal Excha | 1992 |
Outcome of thyroid function in newborns from mothers treated with amiodarone.
Topics: Adult; Amiodarone; Female; Humans; Hypothyroidism; Infant, Newborn; Maternal-Fetal Exchange; Pregnan | 1992 |
Amiodarone therapy of intractable atrial flutter in a premature hydropic neonate.
Topics: Adult; Amiodarone; Atrial Flutter; Electrocardiography; Female; Humans; Hydrops Fetalis; Hypothyroid | 1992 |
Use of amiodarone during pregnancy.
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Fetal Blood; Humans; Hypothyroidism; Infant, Newborn; Lact | 1992 |
[Neonatal hypothyroidism after amiodarone therapy during pregnancy].
Topics: Amiodarone; Female; Humans; Hypothyroidism; Infant, Newborn; Pregnancy; Pregnancy Complications; Pre | 1992 |
Effects of amiodarone administration during pregnancy in Fischer 344 rats.
Topics: Amiodarone; Animals; Birth Weight; Female; Litter Size; Liver; Lung; Maternal-Fetal Exchange; Placen | 1991 |
Iodine induced thyroid disease.
Topics: Amiodarone; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Infant, Newborn; Iodine | 1990 |
[Non-arteriosclerotic myocardial infarction in a 24-year-old patient and unintended use of amiodarone during pregnancy without embryotoxic effects].
Topics: Abnormalities, Drug-Induced; Adult; Amiodarone; Cardiac Complexes, Premature; Coronary Aneurysm; Emb | 1988 |
Neonatal hyperthyroxinaemia associated with maternal amiodarone therapy: case report.
Topics: Adult; Amiodarone; Cardiac Complexes, Premature; Female; Humans; Hyperthyroxinemia; Infant, Newborn; | 1988 |
Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis.
Topics: Adult; Amiodarone; Digoxin; Female; Fetal Diseases; Humans; Hydrops Fetalis; Injections, Intravenous | 1989 |
[Use of amiodarone in pregnant women].
Topics: Adolescent; Adult; Amiodarone; Female; Humans; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complic | 1988 |
Performance of the SimulTRAC free T4/TSH assay during pregnancy and treatment with amiodarone.
Topics: Amiodarone; Female; Humans; Pregnancy; Thyrotropin; Thyroxine | 1988 |
Amiodarone during pregnancy.
Topics: Adolescent; Amiodarone; Breast Feeding; Dose-Response Relationship, Drug; Female; Humans; Infant, Ne | 1988 |
Congenital hypothyroid goiter and amiodarone.
Topics: Adult; Amiodarone; Congenital Hypothyroidism; Female; Goiter; Humans; Hypothyroidism; Infant; Infant | 1988 |
[Hypothyroidism following maternal treatment with amiodarone].
Topics: Amiodarone; Female; Fetal Diseases; Heart Failure; Humans; Hypothyroidism; Infant, Newborn; Male; Ma | 1988 |
[Value of amiodarone in the treatment of fetal supraventricular tachycardia. Apropos of a case].
Topics: Amiodarone; Female; Fetal Diseases; Heart Rate, Fetal; Humans; Pregnancy; Tachycardia, Supraventricu | 1987 |
Anesthetic management of the parturient receiving amiodarone.
Topics: Adult; Amiodarone; Anesthesia, Epidural; Drug Interactions; Female; Fentanyl; Hemodynamics; Humans; | 1987 |
Effects of amiodarone during pregnancy.
Topics: Adult; Amiodarone; Female; Heart Ventricles; Humans; Infant, Newborn; Iodine; Maternal-Fetal Exchang | 1987 |
[Fetal supraventricular tachycardia. Prenatal treatment with a digoxin-amiodarone combination].
Topics: Amiodarone; Digoxin; Drug Therapy, Combination; Female; Fetal Diseases; Humans; Pregnancy; Tachycard | 1987 |
Neonatal hypothyroidism after treatment by amiodarone during pregnancy.
Topics: Adult; Amiodarone; Female; Fetal Diseases; Goiter; Heart Failure; Humans; Infant, Newborn; Maternal- | 1987 |
Amiodarone and digoxin for refractory fetal tachycardia.
Topics: Adult; Amiodarone; Digoxin; Female; Fetal Diseases; Humans; Pregnancy; Tachycardia | 1987 |
Treatment of fetal cardiac arrhythmias.
Topics: Amiodarone; Arrhythmia, Sinus; Arrhythmias, Cardiac; Chromosome Aberrations; Chromosome Disorders; D | 1985 |
The diagnostic challenge of euthyroid hyperthyroxinemia.
Topics: Amiodarone; Autoantibodies; Female; Humans; Hyperemesis Gravidarum; Male; Mental Disorders; Prealbum | 1985 |
Use of amiodarone during pregnancy.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Maternal-Fetal Exchange; Pregn | 1985 |
Amiodarone in pregnancy.
Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Electrocardiography; Female; Fetal Blood; Human | 1985 |
Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone: a case report.
Topics: Adult; Amiodarone; Benzofurans; Female; Fetal Diseases; Fetal Heart; Heart Failure; Heart Rate; Huma | 1985 |